Kari Sørland

Haukeland University Hospital — Norway

Medicine · Health Sciences

9h-index611citations16works1.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Fibromyalgia and Chronic Fatigue Syndrome Research(12), Genetic Neurodegenerative Diseases(3), Peripheral Neuropathies and Disorders(3), Advanced Proteomics Techniques and Applications(2), Long-Term Effects of COVID-19(2)

Publications16 total

Self-reported late effects, daily functioning, and health-related quality of life in older Hodgkin lymphoma survivors - a national population-based cross-sectional survey.
PubMed·2026
Plasma cell targeting with the anti-CD38 antibody daratumumab in myalgic encephalomyelitis/chronic fatigue syndrome—a clinical pilot study
Frontiers in Medicine·2025· 1 citedOpen Access
Charting the Circulating Proteome in ME/CFS: Cross System Profiling and Mechanistic insights
2025Open Access
Charting the Circulating Proteome in ME/CFS: Cross System Profiling and Mechanistic Insights
SSRN Electronic Journal·2025Open Access
Six-year follow-up of participants in two clinical trials of rituximab or cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
PLoS ONE·2024· 6 citedOpen Access
Endothelial dysfunction in ME/CFS patients
PLoS ONE·2023· 41 citedOpen Access
Activity monitoring and patient-reported outcome measures in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients
PLoS ONE·2022· 12 citedOpen Access
A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome
JCI Insight·2021· 61 citedOpen Access
Reduced Endothelial Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome–Results From Open-Label Cyclophosphamide Intervention Study
Frontiers in Medicine·2021· 30 citedOpen Access
Intravenous Cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. An Open-Label Phase II Study
Frontiers in Medicine·2020· 31 citedOpen Access
Searching for Serum Antibodies to Neuronal Proteins in Patients With Myalgic Encephalopathy/Chronic Fatigue Syndrome
Clinical Therapeutics·2019· 11 citedOpen Access
Table of Contents
Clinical Therapeutics·2019Open Access
B-Lymphocyte Depletion in Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Annals of Internal Medicine·2019· 88 cited
Rituximab Serum Concentrations and Anti-Rituximab Antibodies During B-Cell Depletion Therapy for Myalgic Encephalopathy/Chronic Fatigue Syndrome
Clinical Therapeutics·2018· 5 citedOpen Access
Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome
JCI Insight·2016· 201 citedOpen Access
B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment
PLoS ONE·2015· 124 citedOpen Access

Frequent Co-authors

Øystein Fluge(15), Olav Mella(14), Ingrid G. Rekeland(14), Kristin Risa(12), Kine Alme(12), Karl Johan Tronstad(8), Olav Dahl(7), Ove Bruland(5), Alexander Fosså(5), Sissel E. Dyrstad(3), Irini Ktoridou-Valen(3), Katarina Lien(3), Ingrid Herder(3), Hanne Thürmer(3), Christoph Schäfer(3), Fredrik Hoel(3), August Hoel(3), Hans‐Peter Marti(3), Dipak Sapkota(2), Sigrid Lunde(2)